Mercer Global Advisors
CLPT icon

Mercer Global Advisors’s ClearPoint Neuro CLPT Stock Holding History

Mercer Global Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+6,055
New +$75.6K ﹤0.01% 3787

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Mercer Global Advisors's CLPT Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 6,055 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings.

121 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Mercer Global Advisors held 6,055 shares of ClearPoint Neuro worth $108K as of Q2 2026.
  • ClearPoint Neuro was a new Mercer Global Advisors position in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3787 holding.
  • 121 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.